TruScreen Group Limited (TRU.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 798.44 Thousand NZD | -13.98% |
| 2023 | 928.15 Thousand NZD | -6.43% |
| 2022 | 991.89 Thousand NZD | 42.62% |
| 2021 | 695.5 Thousand NZD | -16.5% |
| 2020 | 832.94 Thousand NZD | -32.0% |
| 2019 | 1.22 Million NZD | 122.33% |
| 2018 | 550.96 Thousand NZD | -23.18% |
| 2017 | 717.19 Thousand NZD | 67.01% |
| 2016 | 429.43 Thousand NZD | -45.45% |
| 2015 | 787.21 Thousand NZD | -28.32% |
| 2014 | 1.09 Million NZD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 FY | 798.44 Thousand NZD | -13.98% |
| 2024 Q4 | 798.44 Thousand NZD | 3.78% |
| 2024 Q1 | 846.3 Thousand NZD | -8.82% |
| 2024 Q2 | 846.3 Thousand NZD | 0.0% |
| 2024 Q3 | 769.36 Thousand NZD | -9.09% |
| 2023 Q4 | 928.15 Thousand NZD | 4.43% |
| 2023 Q3 | 888.8 Thousand NZD | 49.53% |
| 2023 Q2 | 594.39 Thousand NZD | 0.0% |
| 2023 Q1 | 594.39 Thousand NZD | -40.07% |
| 2023 FY | 928.15 Thousand NZD | -6.43% |
| 2022 Q4 | 991.89 Thousand NZD | 4.66% |
| 2022 Q2 | 648.98 Thousand NZD | 0.0% |
| 2022 FY | 991.89 Thousand NZD | 42.62% |
| 2022 Q1 | 648.98 Thousand NZD | -6.69% |
| 2022 Q3 | 947.75 Thousand NZD | 46.04% |
| 2021 Q3 | 657.96 Thousand NZD | -32.4% |
| 2021 Q4 | 695.5 Thousand NZD | 5.7% |
| 2021 FY | 695.5 Thousand NZD | -16.5% |
| 2021 Q1 | 973.32 Thousand NZD | 16.85% |
| 2021 Q2 | 973.32 Thousand NZD | 0.0% |
| 2020 Q4 | 832.94 Thousand NZD | 5.9% |
| 2020 FY | 832.94 Thousand NZD | -32.0% |
| 2020 Q3 | 786.57 Thousand NZD | -43.9% |
| 2020 Q2 | 1.4 Million NZD | 0.0% |
| 2020 Q1 | 1.4 Million NZD | 14.47% |
| 2019 FY | 1.22 Million NZD | 122.33% |
| 2019 Q4 | 1.22 Million NZD | 4.39% |
| 2019 Q3 | 1.17 Million NZD | 22.63% |
| 2019 Q1 | 956.87 Thousand NZD | 73.67% |
| 2019 Q2 | 956.87 Thousand NZD | 0.0% |
| 2018 Q1 | 148.29 Thousand NZD | -79.32% |
| 2018 FY | 550.96 Thousand NZD | -23.18% |
| 2018 Q4 | 550.96 Thousand NZD | 4.22% |
| 2018 Q3 | 528.65 Thousand NZD | 256.48% |
| 2018 Q2 | 148.29 Thousand NZD | 0.0% |
| 2017 Q1 | 278.58 Thousand NZD | -35.13% |
| 2017 Q4 | 717.19 Thousand NZD | 0.0% |
| 2017 FY | 717.19 Thousand NZD | 67.01% |
| 2017 Q2 | 278.58 Thousand NZD | 0.0% |
| 2017 Q3 | 717.19 Thousand NZD | 157.44% |
| 2016 Q2 | 524.45 Thousand NZD | 0.0% |
| 2016 FY | 429.43 Thousand NZD | -45.45% |
| 2016 Q4 | 429.43 Thousand NZD | 0.0% |
| 2016 Q3 | 429.43 Thousand NZD | -18.12% |
| 2016 Q1 | 524.45 Thousand NZD | -33.38% |
| 2015 Q3 | 787.21 Thousand NZD | 201.8% |
| 2015 Q1 | 260.84 Thousand NZD | 0.0% |
| 2015 FY | 787.21 Thousand NZD | -28.32% |
| 2015 Q2 | 260.84 Thousand NZD | 0.0% |
| 2015 Q4 | 787.21 Thousand NZD | 0.0% |
| 2014 FY | 1.09 Million NZD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| 4DMedical Limited | 49.08 Million AUD | 98.373% |
| Adherium Limited | 3.4 Million AUD | 76.563% |
| Aroa Biosurgery Limited | 14.77 Million AUD | 94.597% |
| Atomo Diagnostics Limited | 1.29 Million AUD | 38.315% |
| Anteris Technologies Ltd | 17.03 Million AUD | 95.314% |
| Control Bionics Limited | 2.75 Million AUD | 71.067% |
| CardieX Limited | 8.56 Million AUD | 90.675% |
| Compumedics Limited | 22.14 Million AUD | 96.395% |
| Cochlear Limited | 904.6 Million AUD | 99.912% |
| CleanSpace Holdings Limited | 6.94 Million AUD | 88.511% |
| Cyclopharm Limited | 13.65 Million AUD | 94.153% |
| EMVision Medical Devices Ltd | 5.45 Million AUD | 85.365% |
| Nova Eye Medical Limited | 8.55 Million AUD | 90.664% |
| HeraMED Limited | 1.5 Million AUD | 46.98% |
| Imricor Medical Systems, Inc. | 25 Million AUD | 96.807% |
| ImpediMed Limited | 6.24 Million AUD | 87.211% |
| InhaleRx Limited | 911.41 Thousand AUD | 12.395% |
| LBT Innovations Limited | 5.5 Million AUD | 85.504% |
| Micro-X Limited | 12.63 Million AUD | 93.68% |
| Neurotech International Limited | 314.69 Thousand AUD | -153.718% |
| OncoSil Medical Limited | 1.98 Million AUD | 59.715% |
| PolyNovo Limited | 37.04 Million AUD | 97.845% |
| Respiri Limited | 3.55 Million AUD | 77.534% |
| SomnoMed Limited | 24.78 Million AUD | 96.778% |
| Universal Biosensors, Inc. | 10.61 Million AUD | 92.476% |
| Uscom Limited | 2.07 Million AUD | 61.494% |
| Visioneering Technologies, Inc. | 2.76 Million AUD | 71.143% |